glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with epidermal growth factor in 1 studies
Studies (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Trials (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Recent Studies (post-2010) (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
---|---|---|---|---|---|
99 | 1 | 18 | 24,155 | 217 | 4,699 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, J; Hori, M; Ichigo, S; Morishita, S; Tamaya, T | 1 |
1 other study(ies) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and epidermal growth factor
Article | Year |
---|---|
Oestrogen induces c-Ha-ras expression in the fibroblasts derived from human uterine endometrium.
Topics: Adult; Base Sequence; Cell Division; Dose-Response Relationship, Drug; Endometrium; Enzyme Inhibitors; Epidermal Growth Factor; Estradiol; Female; Fibroblasts; Gene Expression Regulation; Genes, ras; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Molecular Sequence Data; Peptide Fragments; Polymerase Chain Reaction; Progesterone; Protein-Tyrosine Kinases; RNA, Messenger; Stromal Cells | 1995 |